Cargando…
Association of XPD Lys751Gln polymorphism with head and neck cancer susceptibility: evidence from 11,443 subjects
BACKGROUND: Whether the single nucleotide polymorphism (SNP) Lys751Gln of xeroderma pigmentosum group D(XPD) gene increases susceptibility to head and neck cancer (HNC) is controversial and undetermined. Therefore, we conducted this meta-analysis to systematically assess the possible association bet...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3916081/ https://www.ncbi.nlm.nih.gov/pubmed/24443924 http://dx.doi.org/10.1186/1746-1596-9-15 |
_version_ | 1782302663512162304 |
---|---|
author | Lin, Hai Lin, Dong Zheng, Chunquan |
author_facet | Lin, Hai Lin, Dong Zheng, Chunquan |
author_sort | Lin, Hai |
collection | PubMed |
description | BACKGROUND: Whether the single nucleotide polymorphism (SNP) Lys751Gln of xeroderma pigmentosum group D(XPD) gene increases susceptibility to head and neck cancer (HNC) is controversial and undetermined. Therefore, we conducted this meta-analysis to systematically assess the possible association between them. METHODS: The OVID, Medline, Embase, Pubmed, Web of Science databases were searched to identify the eligible studies. The odds ratio (OR) with 95% confidence interval (95% CI) were used to assess the strength of association. RESULTS: A total of 11,443 subjects from eighteen studies were subjected to meta-analysis. Overall, XPD Lys751Gln polymorphism had no association with increased HNC risk under all five genetic models (P > 0.05). In the subgroup analysis by ethnicity and source of controls, still no significant association was found under five genetic models (P > 0.05). In the subgroup analysis by cancer type, XPD Lys751Gln polymorphism had statistically significant association with elevated laryngeal cancer (LC) and nasopharyngeal cancer (NPC) risk under heterozygous comparison and dominant model (P<0.05) and borderline significantly increased risk was found under allele contrast for LC and NPC. Carriers of Lys allele and Lys/Lys genotype may be associated with elevated LC and NPC risk. CONCLUSIONS: There is overall lack of association between XPD Lys751Gln polymorphism and HNC risk under all five genetic models and still no significant association was found in the subgroup analysis by ethnicity and source of controls. However, XPD Lys751Gln polymorphism was significantly associated with susceptibility to LC and NPC and the Lys allele and Lys/Lys genotype of XPD Lys751Gln polymorphism may be a risk factor for LC and NPC. However, relatively modest sample sizes were included in this meta-analysis and studies with large sample sizes and representative population are warranted to further clarify this finding. VIRTUAL SLIDES: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/5628716106316015. |
format | Online Article Text |
id | pubmed-3916081 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-39160812014-02-07 Association of XPD Lys751Gln polymorphism with head and neck cancer susceptibility: evidence from 11,443 subjects Lin, Hai Lin, Dong Zheng, Chunquan Diagn Pathol Research BACKGROUND: Whether the single nucleotide polymorphism (SNP) Lys751Gln of xeroderma pigmentosum group D(XPD) gene increases susceptibility to head and neck cancer (HNC) is controversial and undetermined. Therefore, we conducted this meta-analysis to systematically assess the possible association between them. METHODS: The OVID, Medline, Embase, Pubmed, Web of Science databases were searched to identify the eligible studies. The odds ratio (OR) with 95% confidence interval (95% CI) were used to assess the strength of association. RESULTS: A total of 11,443 subjects from eighteen studies were subjected to meta-analysis. Overall, XPD Lys751Gln polymorphism had no association with increased HNC risk under all five genetic models (P > 0.05). In the subgroup analysis by ethnicity and source of controls, still no significant association was found under five genetic models (P > 0.05). In the subgroup analysis by cancer type, XPD Lys751Gln polymorphism had statistically significant association with elevated laryngeal cancer (LC) and nasopharyngeal cancer (NPC) risk under heterozygous comparison and dominant model (P<0.05) and borderline significantly increased risk was found under allele contrast for LC and NPC. Carriers of Lys allele and Lys/Lys genotype may be associated with elevated LC and NPC risk. CONCLUSIONS: There is overall lack of association between XPD Lys751Gln polymorphism and HNC risk under all five genetic models and still no significant association was found in the subgroup analysis by ethnicity and source of controls. However, XPD Lys751Gln polymorphism was significantly associated with susceptibility to LC and NPC and the Lys allele and Lys/Lys genotype of XPD Lys751Gln polymorphism may be a risk factor for LC and NPC. However, relatively modest sample sizes were included in this meta-analysis and studies with large sample sizes and representative population are warranted to further clarify this finding. VIRTUAL SLIDES: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/5628716106316015. BioMed Central 2014-01-20 /pmc/articles/PMC3916081/ /pubmed/24443924 http://dx.doi.org/10.1186/1746-1596-9-15 Text en Copyright © 2014 Lin et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Lin, Hai Lin, Dong Zheng, Chunquan Association of XPD Lys751Gln polymorphism with head and neck cancer susceptibility: evidence from 11,443 subjects |
title | Association of XPD Lys751Gln polymorphism with head and neck cancer susceptibility: evidence from 11,443 subjects |
title_full | Association of XPD Lys751Gln polymorphism with head and neck cancer susceptibility: evidence from 11,443 subjects |
title_fullStr | Association of XPD Lys751Gln polymorphism with head and neck cancer susceptibility: evidence from 11,443 subjects |
title_full_unstemmed | Association of XPD Lys751Gln polymorphism with head and neck cancer susceptibility: evidence from 11,443 subjects |
title_short | Association of XPD Lys751Gln polymorphism with head and neck cancer susceptibility: evidence from 11,443 subjects |
title_sort | association of xpd lys751gln polymorphism with head and neck cancer susceptibility: evidence from 11,443 subjects |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3916081/ https://www.ncbi.nlm.nih.gov/pubmed/24443924 http://dx.doi.org/10.1186/1746-1596-9-15 |
work_keys_str_mv | AT linhai associationofxpdlys751glnpolymorphismwithheadandneckcancersusceptibilityevidencefrom11443subjects AT lindong associationofxpdlys751glnpolymorphismwithheadandneckcancersusceptibilityevidencefrom11443subjects AT zhengchunquan associationofxpdlys751glnpolymorphismwithheadandneckcancersusceptibilityevidencefrom11443subjects |